Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

Novo Holdings invests in Manipal Hospitals, a leading private hospital chain in India

Published

on

novo-holdings-invests-in-manipal-hospitals,-a-leading-private-hospital-chain-in-india

COPENHAGEN, Denmark and SINGAPORE, Feb. 6, 2024 /PRNewswire/ — Novo Holdings today announced its investment in Manipal Hospitals (‘Manipal’), which constitutes Novo Holding’s largest investment in Asia to date. Manipal Hospitals is among the top healthcare providers in India, providing comprehensive curative and preventive care for a multitude of patients within India and from around the globe.

Established in 1991 with the launch of its flagship hospital in Bangalore, Manipal has become one of the pre-eminent private hospital chains in India. The network currently comprises 33 hospitals across the country with a bed capacity of 9,500+, serving an annual footfall of approximately 6 million patients.

A rising middle class, paired with an increased appreciation for advanced medical facilities and quality healthcare services, has driven an uptick in demand for private hospital care in the country. Other factors include the expansion of health insurance coverage and the sophistication of medical technology adopted at private institutions.

Dr. Amit Kakar, Managing Partner and Head of Novo Holdings Asia Investments, said
“The demand for affordable and accessible private healthcare services in India is increasing rapidly, and Manipal stands at the forefront to address patient needs through its consistent growth and ability to provide high-quality patient services at affordable prices. It has a history of several successful mergers and acquisitions, which is enabling patient care closer to home. Together with a highly capable executive team and like-minded investor base, I am excited for Novo Holdings to be part of Manipal’s next phase on its remarkable journey.”

Navjeewan J. Khosla, Partner, Novo Holdings Asia Investments, added
“We are very pleased to announce the investment in Manipal Hospitals. It represents our commitment towards filling the gap between the enormous demand and underserved healthcare infrastructure in India. By offering a vast range of high-end procedures and demonstrating a strong track record of delivering high-quality care at an affordable cost, a strong medical, technical and management team, Manipal is contributing to raising the bar for private hospitals in India.”

About Manipal Hospitals
As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 6 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out of hospital care. With the acquisitions of Columbia Asia Hospitals Private Limited and Vikram Hospital (Bengaluru) Private Limited, the integrated network today has a pan-India footprint of 33 hospitals with 9,500+ beds, and a talented pool of 5,000+ doctors. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH, AAHRPP accredited and most of the hospitals in its network are NABL, ER, Blood Bank accredited and recognised for Nursing Excellence. Manipal Hospitals has also been recognised as the most respected and patient recommended hospital in India through various consumer surveys.

About Novo Holdings A/S
Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk Foundation. The purpose of Novo Holdings is to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.

Wholly owned by the Novo Nordisk Foundation, Novo Holdings is the controlling shareholder of Novo Nordisk A/S and Novozymes A/S and manages an investment portfolio with a long-term return perspective. In addition to managing a broad portfolio of equities, bonds, real estate, infrastructure and private equity assets, Novo Holdings is a world-leading life sciences investor. Through its Seeds, Venture, Growth, and Principal Investments teams, Novo Holdings invests in life science companies at all stages of development.

As of year-end 2022, Novo Holdings had total assets of EUR 108 billion.
www.novoholdings.dk 

About the Novo Nordisk Foundation
Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people’s health and the sustainability of society and the planet. The Foundation’s mission is to progress research and innovation in the prevention and treatment of cardiometabolic and infectious diseases as well as to advance knowledge and solutions to support a green transformation of society.
www.novonordiskfonden.dk/en 

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/novo-holdings-invests-in-manipal-hospitals-a-leading-private-hospital-chain-in-india-302053352.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Blue Ridge Partners Promotes Growth Strategist Nick Walmsley to Managing Director

Published

on

blue-ridge-partners-promotes-growth-strategist-nick-walmsley-to-managing-director

Global consultancy strengthens its European leadership team as part of ongoing growth strategy

LONDON, Nov. 26, 2024 /PRNewswire/ — Blue Ridge Partners is pleased to announce the promotion of Nick Walmsley to Managing Director, strengthening its European leadership team and commitment to client growth across the region.

Nick Walmsley, who joined Blue Ridge Partners in 2017, brings over 20 years of experience in growth strategy and investing. Throughout his tenure with the firm, Nick has consistently delivered exceptional results for clients, and his appointment to Managing Director reflects his dedication and impact. Prior to joining Blue Ridge Partners, Nick was founder and partner of a $500M AUM investment firm involved in over 200 transactions across Europe, North America, and Asia-Pacific. He began his career at Bain & Company, where he served in the private equity practice in both London and San Francisco.

“Nick has been an invaluable member of our team over the past seven years, demonstrating his ability to create value for our clients and our firm,” said Jim Corey, CEO of Blue Ridge Partners. “With his unique blend of consulting, operational, and investment management experience, Nick is exceptionally well-prepared to serve our clients as Managing Director.”

Blue Ridge Partners is delighted to have Nick step into this new role, further enhancing its capabilities to drive client success across Europe.

About Blue Ridge Partners:

Blue Ridge Partners is a global management consulting firm exclusively focused on helping companies accelerate profitable revenue growth. We have worked with more than 1,300 companies to improve their strategic understanding of markets and customers, deepen and expand their customer relationships, and enhance marketing and sales performance.

Our clients include over 130 private equity firms and their portfolio companies – supporting them during deal evaluation, due diligence, and post-acquisition. We have a reputation for helping companies grow faster by rolling up our sleeves, working collaboratively, and delivering measurable impact quickly and more efficiently than large consultancies.

For further information please contact us at [email protected] or visit us at www.blueridgepartners.com.

Blue Ridge Partners The Revenue Engine management consultant logo

Photo – https://mma.prnewswire.com/media/2566976/Nick_Walmsley_Managing_Director_Blue_Ridge_Partners_Managment_Consulting.jpg
Logo – https://mma.prnewswire.com/media/2415897/Blue_Ridge_Partners_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/blue-ridge-partners-promotes-growth-strategist-nick-walmsley-to-managing-director-302315820.html

Advertisement
Continue Reading

Fintech PR

BNP Paribas, AXA and Bloomberg’s former executive joins fintech Premialab

Published

on

bnp-paribas,-axa-and-bloomberg’s-former-executive-joins-fintech-premialab

Diane Lansard, further expands Premialab’s marketing footprint bringing in her extensive banking and asset management expertise to the fintech dedicated to quantitative investment strategies.

LONDON, Nov. 26, 2024 /PRNewswire/ — Premialab announces the appointment of Diane Lansard, as Head of Marketing. Based in London, Ms. Lansard will lead the marketing strategy of the leading independent platform dedicated to quantitative strategies. Before joining PremiaLab, Ms. Lansard served a wide range of institutional clients in buy-and sell-side leadership roles at BNP Paribas, AXA, Bloomberg, and M&G Investments.

Ms. Lansard has over 15 years’ experience in banking, asset management and fintech solutions. She will be responsible to execute and scale Premialab’s marketing initiatives, providing data and analytics solutions to asset managers, pension funds, insurance companies and sovereign wealth funds globally.

Adrien Geliot, CEO of Premialab, said: “We are thrilled to welcome Diane to our team as we continue to scale our presence globally. Her extensive experience in finance and innovative approach to marketing, will play a pivotal role in driving our growth efforts. Diane’s expertise will further strengthen our position as a leader in data and analytics for institutional investors.”

The announcement follows recent senior appointments at Premialab including John Macpherson, former Managing Director at Goldman Sachs, Citibank, and Nomura; Marc Fisher, former Managing Director at Citibank with a prior position at Deutsche Bank; and Georgios Sittas, former Managing Director at HSBC, Standard Chartered, and previously a director at Lehman Brothers.

Recognized as the leading independent platform for data and analytics on quantitative strategies, Premialab’s capital markets infrastructure is currently used by leading institutional investors, accelerating their digitalization and enhancing performance and risk control while reducing costs. The Platform is already providing data to institutional clients representing over $20 Trillion of assets under management.

Notes to Editors

About PremiaLab

Premialabis the leading independent platform providing data, analytics and risk solutions on quantitative and multi-asset strategies in collaboration with leading investment banks and institutional investors globally. Combining intelligent technology with a unique source of information the platform empowers asset allocators to make better investment decisions whilst achieving utmost time and cost efficiency.

With offices in London, Paris, New York, Hong Kong, Sydney, and Dubai, its international team is dedicated to supporting a global client base with the most up-to-date QIS dataset, advanced portfolio construction, performance and risk analytics. The firm has established strong partnerships with the top 18 investments banks, global asset managers, pensions funds and insurance companies.

Advertisement

For more information please visit: www.premialab.com

View original content:https://www.prnewswire.co.uk/news-releases/bnp-paribas-axa-and-bloombergs-former-executive-joins-fintech-premialab-302315533.html

Continue Reading

Fintech PR

Paratus Increases Full-Year 2024 Earnings Guidance and Provides Update on Operations in Mexico

Published

on

paratus-increases-full-year-2024-earnings-guidance-and-provides-update-on-operations-in-mexico

HAMILTON, Bermuda, Nov. 26, 2024 /PRNewswire/ — Paratus Energy Services Ltd. (Oslo: PLSV) (“Paratus” or the “Company”) announces an upward revision of its full-year 2024 EBITDA guidance and provides commentary on the Company’s rig operations in Mexico, operated through its wholly-owned subsidiary Fontis Holdings Ltd. (“Fontis”).

Following strong operational execution year-to-date, Paratus is raising its full-year 2024 EBITDA guidance to $250-260 million, representing a mid-point increase of $25 million from the previous guidance range of $220-240 million. Further details will be provided on the quarterly earnings call on November 29, 2024.

Paratus has noted recent reports regarding a potential temporary reduction in rig activity in Mexico, and consequently the Company wishes to provide an update as well as clarify the potential financial impact to the Company of such dynamics. The contracts for all of Fontis’ jack-ups with the client permit activity to be temporarily ceased for up to 45 days during the contract term, without revenue being generated during such period. However, any deferred days will extend the contract duration accordingly. Fontis has received notification from its client that the Courageous will temporarily cease operations for 45 days due to delays in the client’s preparatory activities at its next location. Operations at the Courageous’ current location is expected to be completed in early December 2024, upon which the rig will remain in standby at its location. The estimated EBITDA impact of a 45-day deferral through the end of the firm contract period is expected to be approximately $3 million.

Paratus has accommodated and priced such flexibility into its contracts in Mexico to allow its client to execute its operations more efficiently. The Company remains highly focused on supporting its client and continuing to strengthen the long-standing relationship it has had for over a decade, and the Company has taken note of the public comments the client has recently provided about its future plans for operations and payments to its suppliers.

This announcement contains information considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. The announcement was published by Baton Haxhimehmedi, CFO of Paratus, on the time and date set out above.

For further information, please contact:
Baton Haxhimehmedi, CFO
[email protected]
+47 406 39 083

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/paratus-energy-services-ltd/r/paratus-increases-full-year-2024-earnings-guidance-and-provides-update-on-operations-in-mexico,c4070673

View original content:https://www.prnewswire.co.uk/news-releases/paratus-increases-full-year-2024-earnings-guidance-and-provides-update-on-operations-in-mexico-302316267.html

Advertisement
Continue Reading

Trending